By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
Over the last 12 months, five Quoin Pharmaceuticals, Ltd. the people running the company bought shares at market prices, about $409,000 in total, and none of them sold.
Biggest single buyer: LANGER DENNIS, Director, with roughly $129,000. C-suite participation is part of the picture here.
19 investment managers listed QNRX in their latest 13F filings (Q2 2026); more funds bought than sold. Looking at the quarterly pattern: Last full quarter: net buying by insiders. Insiders bought in 2 of the last 7 full quarters.
Are insiders buying or selling QNRX stock?
In the last 12 months Quoin Pharmaceuticals, Ltd. insiders made open-market purchases worth about $409,000 and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
When was the last insider trade in QNRX?
The most recent open-market insider trade in QNRX was filed on 2026-09-01.
How many institutions own QNRX?
19 investment managers reported holding QNRX in SEC Form 13F filings for Q2 2026.
Has any member of Congress traded QNRX?
No congressional trades in QNRX were reported in the past two years. The full list is free on CapitalSnitch.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1).
Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).